GIRAUDO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.183
EU - Europa 1.221
AS - Asia 1.135
AF - Africa 40
SA - Sud America 24
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.629
Nazione #
US - Stati Uniti d'America 2.117
CN - Cina 681
IT - Italia 449
DE - Germania 129
FR - Francia 123
GB - Regno Unito 101
KR - Corea 99
JP - Giappone 81
NL - Olanda 66
CZ - Repubblica Ceca 64
VN - Vietnam 64
IN - India 63
CA - Canada 48
RU - Federazione Russa 42
PL - Polonia 41
HK - Hong Kong 32
CH - Svizzera 28
ZA - Sudafrica 26
AT - Austria 25
IE - Irlanda 23
AU - Australia 22
UA - Ucraina 21
SE - Svezia 20
FI - Finlandia 19
IR - Iran 18
TW - Taiwan 18
SG - Singapore 17
ES - Italia 16
TH - Thailandia 16
RO - Romania 12
BR - Brasile 11
BE - Belgio 10
CU - Cuba 8
CL - Cile 7
MX - Messico 7
MY - Malesia 7
HU - Ungheria 6
ID - Indonesia 6
DK - Danimarca 5
EG - Egitto 5
IL - Israele 5
PH - Filippine 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
TR - Turchia 4
HR - Croazia 3
IQ - Iraq 3
NO - Norvegia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
AR - Argentina 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
GH - Ghana 2
KW - Kuwait 2
LT - Lituania 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
KP - Corea 1
LK - Sri Lanka 1
MA - Marocco 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TN - Tunisia 1
YE - Yemen 1
Totale 4.629
Città #
Fairfield 225
Houston 162
Seattle 144
Ashburn 136
Santa Cruz 118
Guangzhou 115
Woodbridge 100
Ann Arbor 99
Buffalo 99
Torino 98
Wilmington 97
Cambridge 92
Shanghai 86
Beijing 70
Milan 63
Dong Ket 46
Wuhan 40
Warsaw 36
Pisa 34
University Park 34
Nanjing 29
Hangzhou 27
Columbus 26
Tokyo 26
Dublin 23
Los Angeles 22
Turin 22
Vienna 22
Chicago 21
San Diego 21
Xian 21
Amsterdam 18
Muizenberg 18
Rome 18
Riva 17
Toronto 17
Las Vegas 16
Council Bluffs 15
Mountain View 15
Taipei 15
Central District 14
Garching 14
New York 14
Ottawa 14
Seoul 14
Bengaluru 13
Boardman 13
Nanning 13
Paris 13
Phoenix 13
Jinan 12
Moncalieri 12
New Orleans 12
San Jose 12
Shenyang 12
Changsha 11
Chengdu 11
Chongqing 11
Des Moines 11
Helsinki 11
Lake Forest 11
San Francisco 11
Clearwater 10
Frankfurt am Main 10
London 10
Changchun 9
Dallas 8
Hamilton 8
Henderson 8
Oerlikon 8
Orsay 8
Zhengzhou 8
Barcelona 7
Boston 7
Central 7
Cheyenne 7
Fuzhou 7
Singapore 7
Zurich 7
Cardiff 6
Duncan 6
Lappeenranta 6
Leipzig 6
Nanchang 6
San Mateo 6
Suzhou 6
Absecon 5
Bangkok 5
Beaverton 5
Hanoi 5
Hyderabad 5
Mumbai 5
New Kensington 5
Rotterdam 5
Saarbrücken 5
Surat 5
Tianjin 5
Atlanta 4
Boulder 4
Collegno 4
Totale 2.820
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-7e04-2581-e053-d805fe0acbaa 750
Regulation of HMGCoA reductase Activity by Policosanol and Octacosadienol, a New synthetic Analogue of Octacosanol, file e27ce426-ad3b-2581-e053-d805fe0acbaa 491
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor., file e27ce427-ad2c-2581-e053-d805fe0acbaa 419
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers, file e27ce429-c0de-2581-e053-d805fe0acbaa 208
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform., file e27ce426-daf1-2581-e053-d805fe0acbaa 201
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling, file e27ce42a-c382-2581-e053-d805fe0acbaa 200
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature, file e27ce42c-9a05-2581-e053-d805fe0acbaa 193
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination, file e27ce427-00cf-2581-e053-d805fe0acbaa 174
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis, file e27ce42c-cfbd-2581-e053-d805fe0acbaa 170
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice, file e27ce427-b559-2581-e053-d805fe0acbaa 167
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity, file e27ce429-5269-2581-e053-d805fe0acbaa 155
Class 3 semaphorins in cardiovascular development, file e27ce429-d82c-2581-e053-d805fe0acbaa 144
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce42d-6655-2581-e053-d805fe0acbaa 136
The role of semaphorins and their receptors in vascular development and cancer, file e27ce429-c0dc-2581-e053-d805fe0acbaa 130
NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE, file e27ce42b-8da8-2581-e053-d805fe0acbaa 127
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance, file e27ce430-deb4-2581-e053-d805fe0acbaa 121
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth, file e27ce430-afd1-2581-e053-d805fe0acbaa 118
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program, file e27ce42c-5624-2581-e053-d805fe0acbaa 97
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition, file e27ce431-d181-2581-e053-d805fe0acbaa 93
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner, file e27ce431-d183-2581-e053-d805fe0acbaa 93
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM, file e27ce42d-c4a1-2581-e053-d805fe0acbaa 79
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction, file e27ce431-ed1e-2581-e053-d805fe0acbaa 74
Semaphorins in cardiovascular medicine., file e27ce427-0ec9-2581-e053-d805fe0acbaa 69
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy, file e27ce42d-4b85-2581-e053-d805fe0acbaa 66
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability., file e27ce429-2a97-2581-e053-d805fe0acbaa 60
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary, file f467243d-e2e6-4d44-be45-04254066dc40 52
PlexinB1 deficiency in the microenvironment inhibits tumor growth and metastatic dissemination in mouse models of triple negative breast cancer, file d4557c49-4779-4d14-8aec-e8e4e4052a22 43
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression, file fa14c902-131c-4603-a4d2-23ed97a4cad4 29
Medical use of combinations of non-natural semaphorins 3 and antimetabolites, file e27ce42e-db0c-2581-e053-d805fe0acbaa 23
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-fd74-2581-e053-d805fe0acbaa 22
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bb56-2581-e053-d805fe0acbaa 20
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature, file e27ce432-4a3d-2581-e053-d805fe0acbaa 19
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression, file 8d5c83bc-ca94-462b-bcbb-0bda8b642def 17
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability, file 3c64135f-5ed1-4b51-b6e9-afaab6c77b52 13
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability., file e27ce427-dab3-2581-e053-d805fe0acbaa 7
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-77f6-2581-e053-d805fe0acbaa 7
Breast cancers as ecosystems: a metabolic perspective, file 7f880748-81d1-4d72-9e14-7b5d37d4e117 5
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression, file 87b4a0af-4fb6-41bd-96e2-b20447cd1e45 5
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bcf1-2581-e053-d805fe0acbaa 5
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front, file e27ce42d-2467-2581-e053-d805fe0acbaa 3
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42d-2659-2581-e053-d805fe0acbaa 3
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42d-2aec-2581-e053-d805fe0acbaa 3
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce42d-736a-2581-e053-d805fe0acbaa 3
Semaphorins in cardiovascular medicine., file e27ce427-0ec8-2581-e053-d805fe0acbaa 2
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42c-f112-2581-e053-d805fe0acbaa 2
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models, file e27ce42d-4b81-2581-e053-d805fe0acbaa 2
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce432-515e-2581-e053-d805fe0acbaa 2
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation, file e27ce42c-bb7d-2581-e053-d805fe0acbaa 1
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation, file e27ce42c-bb7e-2581-e053-d805fe0acbaa 1
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce432-4e12-2581-e053-d805fe0acbaa 1
Totale 4.825
Categoria #
all - tutte 8.145
article - articoli 0
book - libri 0
conference - conferenze 1.109
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019217 0 0 0 0 0 0 0 0 0 0 130 87
2019/2020994 175 60 46 105 69 70 74 87 74 79 73 82
2020/2021945 55 69 60 83 92 60 93 76 85 88 96 88
2021/20221.026 97 84 59 136 112 42 84 65 58 66 147 76
2022/2023671 26 59 147 101 44 57 58 45 42 40 36 16
2023/2024306 39 50 26 24 19 7 27 37 6 17 54 0
Totale 4.825